Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cihan Ay

Showing results (311-320 of 344) with videos related to

Pageof 35
Sort By:
International Journal of Molecular Sciences|January 11, 2024
Catastrophic Antiphospholipid SyndromeVictoria Bitsadze, Fidan Yakubova, Jamilya Khizroeva, et al.
Journal of Hepatology|January 23, 2022
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLDBernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 16, 2024
Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT studyGloria M Steiner-Gager, Jovan Rogozarski, Christina Kronberger, et al.
Viruses|February 26, 2022
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism RegistryBehnood Bikdeli, David Jiménez, Pablo Demelo-Rodriguez, et al.
JACC. Cardiooncology|January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint InhibitorsFlorian Moik, Jakob M Riedl, Dominik Barth, et al.
Journal of Thrombosis and Haemostasis : JTH|August 19, 2023
Moving against thrombosis: ISTH recognizes 10th anniversary of World Thrombosis Day and the leaders in the field who led the way - in memory of Claire McLintock, MD, World Thrombosis Day Steering Committee Vice Chair 2019 to 2022Louise St Germain, Erich De Paula, Cihan Ay, et al.
Thrombosis Research|September 20, 2020
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 monthsGiancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, et al.
European Journal of Internal Medicine|August 23, 2020
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countriesAlexander T Cohen, Ulrich Hoffmann, Philippe Hainaut, et al.
European Heart Journal|December 7, 2021
Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory SocietyFrederikus A Klok, Walter Ageno, Cihan Ay, et al.
Thrombosis and Haemostasis|September 10, 2021
New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with HemophiliaJan Astermark, Cihan Ay, Manuela Carvalho, et al.
Pageof 35

Showing results (311-320 of 344) with videos related to

Sort By:
Pageof 35
International Journal of Molecular Sciences|January 11, 2024
Catastrophic Antiphospholipid SyndromeVictoria Bitsadze, Fidan Yakubova, Jamilya Khizroeva, et al.
Journal of Hepatology|January 23, 2022
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLDBernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 16, 2024
Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT studyGloria M Steiner-Gager, Jovan Rogozarski, Christina Kronberger, et al.
Viruses|February 26, 2022
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism RegistryBehnood Bikdeli, David Jiménez, Pablo Demelo-Rodriguez, et al.
JACC. Cardiooncology|January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint InhibitorsFlorian Moik, Jakob M Riedl, Dominik Barth, et al.
Journal of Thrombosis and Haemostasis : JTH|August 19, 2023
Moving against thrombosis: ISTH recognizes 10th anniversary of World Thrombosis Day and the leaders in the field who led the way - in memory of Claire McLintock, MD, World Thrombosis Day Steering Committee Vice Chair 2019 to 2022Louise St Germain, Erich De Paula, Cihan Ay, et al.
Thrombosis Research|September 20, 2020
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 monthsGiancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, et al.
European Journal of Internal Medicine|August 23, 2020
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countriesAlexander T Cohen, Ulrich Hoffmann, Philippe Hainaut, et al.
European Heart Journal|December 7, 2021
Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory SocietyFrederikus A Klok, Walter Ageno, Cihan Ay, et al.
Thrombosis and Haemostasis|September 10, 2021
New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with HemophiliaJan Astermark, Cihan Ay, Manuela Carvalho, et al.
Pageof 35